Literature DB >> 16080671

Incidence of hypertrophic scars among African Americans linked to vitamin D-3 metabolism?

Gerald L Cooke1, Anna Chien, Amy Brodsky, Raphael C Lee.   

Abstract

The pathogenesis and progression of wound-healing involve intricate pathways and numerous chemical mediators. This remains an area of intense study as undesirable results of this process, such as hypertrophic scars and keloids, can result in significant morbidity. These lesions are distinct in their characteristics, although they are similar in their distribution in patients with darker skin colors. There is a robust inflammatory mechanism behind the formation of hypertrophic scars and keloids. Furthermore, their development may be intimately related to vitamin D-3, which has been shown to be a powerful anti-inflammatory agent. This chemical is made in the skin, whose production is influenced by various factors of which the amount of melanin is a crucial one. More specifically, an increase in pigmentation has been shown to decrease the amount of vitamin D-3 synthesis in the skin. Thus, this paper proposes the hypothesis linking the propensity of inflammation and subsequent scarring in darker-skinned individuals to the reduced levels of vitamin D-3 production in their skin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080671      PMCID: PMC2569323     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  22 in total

1.  Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair.

Authors:  C Soo; F Y Hu; X Zhang; Y Wang; S R Beanes; H P Lorenz; M H Hedrick; R J Mackool; A Plaas; S J Kim; M T Longaker; E Freymiller; K Ting
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  p53 Is required for 1,25-dihydroxyvitamin D3-induced G0 arrest but is not required for G1 accumulation or apoptosis of LNCaP prostate cancer cells.

Authors:  Tara C Polek; LaMonica V Stewart; Elizabeth J Ryu; Michael B Cohen; Elizabeth A Allegretto; Nancy L Weigel
Journal:  Endocrinology       Date:  2003-01       Impact factor: 4.736

3.  Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression.

Authors:  M Linker-Israeli; D J Wallace; J Prehn; D Michael; M Honda; K D Taylor; M Paul-Labrador; N Fischel-Ghodsian; P A Fraser; J R Klinenberg
Journal:  Genes Immun       Date:  1999-09       Impact factor: 2.676

4.  Confocal microscopic analysis of scarless repair in the fetal rat: defining the transition.

Authors:  Steven R Beanes; Fei-Ya Hu; Chia Soo; Catherine M H Dang; Mark Urata; Kang Ting; James B Atkinson; Prosper Benhaim; Marc H Hedrick; H Peter Lorenz
Journal:  Plast Reconstr Surg       Date:  2002-01       Impact factor: 4.730

5.  Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair.

Authors:  K W Liechty; N S Adzick; T M Crombleholme
Journal:  Cytokine       Date:  2000-06       Impact factor: 3.861

6.  Elevated interleukin-6 expression in keloid fibroblasts.

Authors:  H Xue; R L McCauley; W Zhang
Journal:  J Surg Res       Date:  2000-03       Impact factor: 2.192

7.  Regulation of IL-6 and IL-8 expression in rheumatoid arthritis synovial fibroblasts: the dominant role for NF-kappa B but not C/EBP beta or c-Jun.

Authors:  C Georganas; H Liu; H Perlman; A Hoffmann; B Thimmapaya; R M Pope
Journal:  J Immunol       Date:  2000-12-15       Impact factor: 5.422

8.  Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children.

Authors:  E F Elst; L W Van Suijlekom-Smit; A P Oranje
Journal:  Pediatr Dermatol       Date:  1999 Jan-Feb       Impact factor: 1.588

9.  A study of cytokines in burn blister fluid related to wound healing.

Authors:  I Ono; H Gunji; J Z Zhang; K Maruyama; F Kaneko
Journal:  Burns       Date:  1995-08       Impact factor: 2.744

10.  1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts.

Authors:  H Harant; B Wolff; I J Lindley
Journal:  FEBS Lett       Date:  1998-10-09       Impact factor: 4.124

View more
  5 in total

1.  Visual outcome of ranibizumab therapy for neovascular age related macular degeneration in the black population: a report of five cases.

Authors:  Roopa Vemala; Bhaskar Gupta; Sobha Sivaprasad
Journal:  Clin Ophthalmol       Date:  2010-08-19

Review 2.  High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars.

Authors:  Dylan E Lee; Ryan M Trowbridge; Nagi T Ayoub; Devendra K Agrawal
Journal:  Plast Reconstr Surg Glob Open       Date:  2015-07-08

Review 3.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

4.  In-depth examination of hyperproliferative healing in two breeds of Sus scrofa domesticus commonly used for research.

Authors:  Colton H Funkhouser; Liam D Kirkpatrick; Robert D Smith; Lauren T Moffatt; Jeffrey W Shupp; Bonnie C Carney
Journal:  Animal Model Exp Med       Date:  2021-11-22

5.  Vitamin D Clinical Pharmacology: Relevance to COVID-19 Pathogenesis.

Authors:  Paige-Ashley Campbell; Mimi Wu Young; Raphael C Lee
Journal:  J Natl Med Assoc       Date:  2020-11-02       Impact factor: 1.798

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.